Research Posts on Medivizor
Navigation Menu

Research Posts on Medivizor

Can 3D scans improve the outcomes of patients with prostate cancer undergoing robotic removal of the prostate?

Can 3D scans improve the outcomes of patients with prostate cancer undergoing robotic removal of the prostate?

Posted by on Jan 26, 2025 in Prostate cancer | 0 comments

In a nutshell This study evaluated the effect of 3-dimensional (3D) digital models to plan robotic-assisted laparoscopic radical prostatectomy (RALP) on the outcomes of patients with prostate cancer (PCa). The data showed that 3D digital models significantly improved the outcomes of these patients. Some background PCa is one of the most...

Read More

Comparing prostate artery embolisation to medical treatment in men with enlarged prostates

Comparing prostate artery embolisation to medical treatment in men with enlarged prostates

Posted by on Jan 26, 2025 in Benign prostatic hyperplasia | 0 comments

In a nutshell This study evaluated the effectiveness and safety of prostate artery embolization (PAE) compared to dutasteride (Avodart) and tamsulosin (Flomax) as the first alternative treatment for benign prostatic hyperplasia (BPH) in patients who had not received previous treatment. The study found that PAE was more effective than medical...

Read More

Evaluating the pulsed solid-state Thulium: YAG laser in men with benign prostatic hyperplasia in a real-world setting

Evaluating the pulsed solid-state Thulium: YAG laser in men with benign prostatic hyperplasia in a real-world setting

Posted by on Oct 13, 2024 in Benign prostatic hyperplasia | 0 comments

In a nutshell This study evaluated the real-world experiences of patients treated with endoscopic enucleation of the prostate (EEP) with the solid-state Thulium laser system (Thulio) for benign prostatic hyperplasia (BPH) treatment. The studies concluded that Thulium laser EEP was a safe and effective treatment option for these...

Read More

Comparing the safety and effectiveness of hormonal therapy alone versus chemo-hormonal therapy before prostate surgery in men with locally advanced prostate cancer

Comparing the safety and effectiveness of hormonal therapy alone versus chemo-hormonal therapy before prostate surgery in men with locally advanced prostate cancer

Posted by on Oct 13, 2024 in Prostate cancer | 0 comments

In a nutshell This study investigated whether adding docetaxel (Taxotere) chemotherapy to standard hormonal therapy (HT) before radical prostatectomy (RP – prostate-removal surgery) improved the survival of men with locally advanced prostate cancer (PCa) compared to hormonal therapy alone. It concluded that the addition of...

Read More

Is there an association between the use of antidiabetic drugs and erectile dysfunction?

Is there an association between the use of antidiabetic drugs and erectile dysfunction?

Posted by on Sep 29, 2024 in Erectile dysfunction | 0 comments

In a nutshell This study examined whether there is an association between the use of antidiabetic drugs and erectile dysfunction (ED). It found that the use of gliclazide (Diamicron) and metformin (Glucophage) increased the risk of ED development. At the same time, there was no association between insulin use and the risk of ED...

Read More

Evaluating the safety and effectiveness of transperineal laser ablation of the prostate for men with enlarged prostates

Evaluating the safety and effectiveness of transperineal laser ablation of the prostate for men with enlarged prostates

Posted by on Sep 8, 2024 in Benign prostatic hyperplasia | 0 comments

In a nutshell This study aimed to evaluate the effectiveness and safety of transperineal laser ablation (TPLA) of the prostate for patients with lower urinary tract symptoms (LUTS) due to an enlarged prostate. The data showed that TPLA was effective and safe for these patients. Some background Lower urinary tract symptoms (LUTS) such as urination...

Read More

Evaluating a double dose of tamsulosin in the management of patients with BPH not responding to standard tamsulosin treatment

Evaluating a double dose of tamsulosin in the management of patients with BPH not responding to standard tamsulosin treatment

Posted by on Aug 20, 2024 in Benign prostatic hyperplasia | 0 comments

In a nutshell This study evaluated the effectiveness and safety of giving a double dose of tamsulosin (Flomax; 0.8 mg per day) to patients with benign prostatic hyperplasia (BPH) who did not respond to the standard tamsulosin dose (0.4 mg per day) and who could not have prostate surgery. The data showed that a double dose of tamsulosin was an...

Read More